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EPIDEMIOLOGY
Missed Study Visits and Subsequent HIV Incidence Among
Women in a Predominantly Sex Worker Cohort Attending
a Dedicated Clinic Service in Kampala, Uganda
Ivan Kasamba, MSc,a,b Stephen Nash, MSc,b,c Maryam Shahmanesh, PhD,d Kathy Baisley, MSc,b
Jim Todd, MSc,b Onesmus Kamacooko, MSc,a Yunia Mayanja, MSc,a Janet Seeley, PhD,a,b and
Helen A. Weiss, PhDb,c
Background: There is limited evidence on the relationship
between sustained exposure of female sex workers (FSWs) to
targeted HIV programmes and HIV incidence. We investigate the
relationship between the number of missed study visits (MSVs)
within each episode of 2 consecutively attended visits (MSVs) and
subsequent HIV risk in a predominantly FSW cohort.
Methods: Women at high risk of HIV are invited to attend an
ongoing dedicated clinic offering a combination HIV prevention
intervention in Kampala, Uganda. Study visits are scheduled once
every 3 months. The analysis included HIV-seronegative women
with $1 follow-up visit from enrollment (between April 2008 and
May 2017) to August 2017. Cox regression models were ﬁtted
adjusted for characteristics on sociodemographic, reproductive,
behavioral, and sexually transmitted infections (through clinical
examination and serological testing for syphilis).
Findings: Among 2206 participants, HIV incidence was 3.1/100
(170/5540) person-years [95% conﬁdence interval (CI): 2.6 to 3.5].
Incidence increased from 2.6/100 person-years (95% CI: 2.1 to 3.2)
in episodes without a MSV to 3.0/100 (95% CI: 2.2 to 4.1) for 1–2
MSVs and 4.3/100 (95% CI: 3.3 to 5.6) for $3 MSVs. Relative to
episodes without a MSV, the hazard ratios (adjusted for confounding
variables) were 1.40 (95% CI: 0.93 to 2.12) for 1–2 MSVs and 2.00
(95% CI: 1.35 to 2.95) for $3 MSVs (P-trend = 0.001).
Conclusion: Missing study visits was associated with increased
subsequent HIV risk. Although several factors may underlie this
association, the ﬁnding suggests effectiveness of targeted combina-
tion HIV prevention. But exposure to targeted interventions needs to
be monitored, facilitated, and sustained in FSWs.
Key Words: HIV, HIV incidence, missed study visits, female sex
workers, sub-Saharan Africa
(J Acquir Immune Deﬁc Syndr 2019;82:343–354)
INTRODUCTION
Combination of HIV-prevention programmes targeting
sex workers is cost-effective, especially in settings with high
HIV incidence and prevalence among sex workers.1,2 How-
ever, when HIV prevention in sex work is not sustained in
these settings, there can be rapid HIV acquisition and onward
HIV transmission beyond female sex workers (FSWs) and
their clients to the wider population.3 In Uganda, a systematic
review of epidemiological data among FSWs showed an
estimated HIV prevalence in the range of 32%–52%, which is
4–7 times that in adult women in the general population.4,5
Although there is sufﬁcient evidence that supports effective-
ness of multicomponent-targeted HIV interventions for
FSWs, sustaining exposure to these interventions remains
a major challenge.6–9
The WHO recommends routinely offering evidence-
based comprehensive HIV-prevention services to key pop-
ulations such as FSWs, which includes HIV counseling and
testing (HCT), and diagnosis and treatment of sexually
transmitted infections (STIs).10 This regular exposure to
services is likely to reinforce behavioral messages, to
facilitate community empowerment, and to detect and treat
STIs early among FSWs.8 Furthermore, regular exposure to
HCT can facilitate earlier initiation of antiretroviral therapy
(ART) during the acute and early infectious phases of HIV.
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Notwithstanding the limited coverage for FSW-targeted
services across Africa, several factors exist at multiple levels
that facilitate or deter FSWs from using services.11–13 The
most commonly identiﬁed contextual factors are stigma,
discrimination, and criminalization and their associated
consequences.14–16 However, other contextual factors such
as the high mobility among sex workers have been identiﬁed
to delay the utilization of services.16,17 These contextual
factors typically act through the individual factors such as
perceptions of HIV risk and importance of services as well as
behavioral (sexual and substance abuse), reproductive, and
biological characteristics (Fig. 1).14,15 At the same time, these
key determinants of service utilization are also important risk
factors for HIV infection among FSWs.18–20
Although there is growing interest in improving service
utilization among FSWs, it remains unclear how recent levels
of service attendance are associated with subsequent HIV
risk.14,19,20 Using the proportions of study visits completed,
research has linked reduced incidence of HIV and other STIs
among FSWs to amount of exposure to targeted HIV
interventions such as peer-mediated HIV education, condom
promotion, risk-reduction interventions, and presumptive treat-
ment for STIs.21–23 However, assessment of the HIV risk
associated with previous recent levels of service attendance
may offer better evidence for risk associated with intervention
exposure because an individual’s level of attendance can vary
over time and for different reasons. If we understand this
relationship better, we could then inform the design and scale-
up of appropriate interventions in sex work.
In a Kenyan FSW cohort with monthly clinic visits
followed for a median of 16.2 months, a time-varying
preceding gap in clinic attendance of $60 days was associated
with reduced HIV risk.24 But this variable of preceding gap in
clinic attendance in this study was only considered as
a confounding variable and, thus, warrants further investigation
as a main exposure of interest. As a main exposure, a different
approach that considers the conceptual interrelationships with
potential confounders and their relationship with HIV risk
should be applied. Furthermore, instead of assigning the date of
seroconversion as midpoint between the last-negative and ﬁrst-
positive test dates, we assigned a random date in this interval,
thereby reducing on the artifactual clustering of seroconversion
times in the middle of observation periods with missed
scheduled testing.25,26
Therefore, the aim of this study was to examine the
association between the number of missed study visits
(MSVs) within episodes of 2 consecutively attended visits
and subsequent HIV risk in a predominantly FSW cohort
attending a dedicated clinic in Kampala, Uganda.
METHODS
Study Population
Between March 2008 and May 2009 (cohort-1), the
Good Health for Women Project (GHWP) enrolled women
acknowledging being FSWs or working in entertainment
facilities such as bars, night clubs, or lodges (women at high
risk of HIV infection) in Kampala, Uganda.27 Participants
were scheduled to attend the study clinic once every 3
months, which is consistent with the Uganda Ministry of
Health guidelines for HCT of key populations.28 From
January 2013 (cohort-2), more participants were continuously
enrolled into GHWP alongside cohort-1 participants.
FIGURE 1. Conceptual framework linking factors leading to MSVs and subsequent HIV incidence used to fit the Cox regression
model within the GHWP. IEC, information education communication; SRH, sexual and reproductive health.
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The procedures for recruiting, screening, enrolling, and
following up of cohort-1 participants have been described in
detail elsewhere.27 But, identical procedures were followed
for cohort-2. Brieﬂy, outreach workers visited and assessed
study eligibility for women at high risk of HIV infection who
had been recruited by peer educators or contacted through
evening community-outreach HCT sessions. Women were
eligible if they were involved in commercial sex (self-
identiﬁed FSWs or received money, goods, or other favors
in exchange for sex) or employed in entertainment facilities
within mapped sex work hotspots (clusters of bars, night
clubs, lodges, and guest houses providing rooms for sex work
or street spots frequented by sex workers). Those who were
eligible were invited to attend the study clinic for rescreening
and study enrollment.
Targeted Intervention
The GHWP intervention follows the WHO standard
framework for HIV prevention in FSWs; aiming at reducing
condomless sex, decreasing HIV transmission efﬁciency,
and empowering FSWs.29 This intervention integrates sex
worker–friendly HIV services with other sexual and repro-
ductive health services and offers free general health care for
participants and their children aged 5 years younger. Table 1
shows the detailed components of the intervention broadly
classiﬁed as structural, behavioral, and biomedical.
At each visit, HIV-preventive behaviors were pro-
moted to each participant, but the content of the counsel-
ing sessions was depended on each participant’s
behavioral responses, outcomes of clinical examinations,
and serological test results. Low-risk participants were
encouraged to maintain behavior, whereas those with risky
behaviors were supported to acknowledge the behavior
and its possible consequences. In addition, high-risk
participants were encouraged to take immediate steps to
reduce the risk associated with behaviors such as harmful
alcohol use or inconsistent condom use. Depending on
their identiﬁed needs, participants were also counseled on
a wide range of other physical and psychosocial issues
including their general health, family, spiritual needs,
and employment.
TABLE 1. HIV-Prevention Intervention Available at the GHWP by the Type of Intervention
Type of Intervention Components Delivery
Behavioral Condom promotion, demonstration, and free condom
distribution
Each visit
Sexual counseling Each visit
Excessive alcohol use counseling including the AUDIT*
questionnaire as part of the motivational interviewing
Each visit
Knowledge of HIV status through HIV testing Each visit and at moonlight outreaches to sex work
hotspots
If diagnosed with HIV, offered positive prevention
strategies, treatment adherence counseling, and HIV
care
Each visit and at ART reﬁll visits
Information sharing and health education Each visit and at the group meetings held fortnightly for
participants with upcoming visits
General counseling services Each visit
Biomedical Syndromic management of sexually transmitted
infections
Each visit
Referrals to other collaborating service providers for
participants in need of postexposure prophylaxis
As needed
Antiretroviral therapy (ART)† if diagnosed with HIV As needed
Structural Access to a free sex worker–friendly dedicated clinic As needed
Sexual and reproductive health services including
antenatal care and contraceptive provision
Every visit and as needed
Free general health care and their children aged,5 years
old
As needed
Support by peer support network As needed
Outreach HIV counseling and testing, and supply of
condoms and health information at the sex work
hotspots
Two nights a week, with a team that includes peer
educators, venue managers, and study staff
Community mobilization involving police, venue
managers and owners, and local authorities
Quarterly meetings
Protection services and referrals to community-based
organizations in case of gender-based violence
As needed
*Alcohol Use Disorders Identiﬁcation Test (AUDIT) was initiated in April 2012, but there was ongoing risk-reduction counseling.
†ART became available at the clinic in January 2013 (eligibility: CD4 cell counts ,350 cells/ml, and from August 2014, for all diagnosed with HIV regardless of CD4 cell count),
but before that participants with CD4 cell count below 250 cells/ml were referred to HIV care providers.
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To ensure high retention, group meetings were held
every 14 days at the study clinic with women who had
scheduled visits within the following month. Participants with
2 or more consecutive MSVs were contacted by phone or
traced in the community (either at their workplace or home)
through a peer leader or the local council member of the
respective area and then invited to attend the clinic at an
appointed time.
Data
At the clinic, trained nurse-counselors used structured
questionnaires to collect data on sociodemographics, sexual
behavior, reproductive health, and substance abuse (alcohol
use and illicit drug use). Data were collected only at
enrollment for age, education level, source of income (sex
work alone or sex work and other jobs), place of client
recruitment (street, bar, club or restaurant, and several
avenues), and number of children. However, data collected
at enrollment and follow-up visits included marital status and
behavioral variables such as alcohol use, illicit drug use,
number of sexual partners, number of paying sexual partners,
frequency of condom use with clients, report of any paid sex
in the last month, and contraceptive use and pregnancy.
Pregnancy was determined using human chorionic gonado-
tropin urine sample tests or visible pregnancy.
A participant had an STI if he/she had an active syphilis
infection (rapid plasma reagin titers $1:8) and positive
Treponema pallidum hemagglutination assay based on serol-
ogy tests conducted at 6-month intervals or had any of the STI
symptoms of abnormal vaginal discharge, genital ulcer
disease syndrome, or pelvic inﬂammatory disease. Between
2008 and 2010, endocervical and vaginal swabs were also
used to detect Neisseria gonorrhoeae, Chlamydia trachoma-
tis, Mycoplasma genitalium, and bacterial vaginosis.
Outcome Variable
The primary outcome was HIV seroconversion, which
was deﬁned as a negative test result at a given visit attended
followed by a positive result at the subsequent visit. Testing
for HIV followed the Uganda MoH algorithm for HIV testing.
According to this algorithm, HIV screening was performed
using Determine HIV-1/2 (Abbott Diagnostics, Maidenhead,
United Kingdom). Before 2013, reactive results were con-
ﬁrmed using 2 enzyme immunoassay tests for HIV screening
(Vironostika Uniform II plus O, Murex HIV 1.2.0) and then
a Western Blot Test. But from 2013, conﬁrmation was done
using Stat-Pak dipstick HIV-1/2 (Chembio Diagnostics), and
discordant samples were further tested with the Uni-Gold
HIV-/2 (Trinity Biotech, Ireland). Participants were included
in this analysis if they tested HIV-negative at enrollment and
had at least one follow-up visit by 29th August 2017
(administrative censoring date). The total person-years (pyr)
for each participant were calculated from their enrollment
date to the earliest of (1) estimated date of seroconversion for
seroconverters or (2) last known HIV-negative test date for
nonseroconverters. The approach for estimating the date of
seroconversion is described under the statistical
analysis section.
Exposure Variable
The number of MSVs within each participant’s epi-
sodes of 2 consecutively attended visits was used to deﬁne the
exposure of interest. This exposure variable is a proxy for the
extent of exposure to and engagement with the combined
components of the HIV intervention offered at the clinic. We
classiﬁed a scheduled study visit as missed if the participant
did not attend the study clinic within 14 days before and 76
days after the scheduled visit date. At each follow-up visit, the
number of scheduled visits that the participant consecutively
missed since the previous visit attended was calculated,
resulting in a time-varying exposure variable. However,
because the exposure variable is likely to have sparse data
for higher numbers of MSVs, we categorized the counts of
MSV into 3 levels: (1) no missed visit, (2) 1–2 MSV, and (3)
$3 MSV.
Statistical Analysis
The total person-years of observation for each partic-
ipant were split according to their number of episodes of
attendance represented by the time period between 2 consec-
utively attended visits. Each episode was then assigned an
appropriate category for the 3-level MSV variable deﬁned
previously. There would be increased uncertainty for the date
of seroconversion during episodes with MSVs while estimat-
ing the person-years for seroconverters. To address this
potential concern, the date of seroconversion was assigned
as a random date from a uniform distribution bounded by the
last-negative and ﬁrst-positive test dates. In addition, the
variability due to assigning a random date was accounted for
by multiple imputations (200 imputations). For each set of
imputed seroconversion dates, the HIV incidence rates and
crude and adjusted hazard ratios (aHR) were calculated and
combined using Rubin’s rules.30
To facilitate identifying potential confounders for the
association between MSV and HIV incidence, we examined
factors associated with MSV using repeated-measures
ordered logistic regression. In this model, the three-level
MSV variable was ﬁtted as the outcome. Within-woman
clustering due to repeated measures was accounted for using
the random-effects model. We also examined factors associ-
ated with HIV infection.
All models included an indicator variable for cohort (1
or 2) and age group a priori. The incidence analysis was
performed in 3 stages: ﬁrst, the association between MSV and
HIV seroconversion was examined using Cox regression
models that included the cohort indicator and age. Second,
sociodemographic, behavioral, reproductive health, and STIs
characteristics were added individually to the base model to
assess whether the crude association persisted. Third, the ﬁnal
model was adjusted for variables that were likely confounders
of the MSV and HIV seroconversion relationship (ie, at least
a 10% change in the log-transformed MSV effects). As
a sensitivity analysis, results from the ﬁnal model were
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TABLE 2. Comparing the Enrollment Characteristics for HIV-
Negative Women With and Without a Follow-up Visit
Characteristic
Follow-up Status, n (%)
At Least One
Follow-up
No Follow-
up Visit P
Number enrolled 2206 878
Sociodemographic
Age in years ,0.001
,24 891 (41.0) 459 (54.1)
25–34 985 (45.3) 321 (37.8)
35+ 299 (13.7) 69 (8.1)
Missing 31 29
Highest education level 0.94
Less than primary 863 (41.3) 328 (42.0)
Completed primary to
incomplete O level
889 (42.6) 330 (42.3)
Completed secondary
ordinary level above
336 (16.1) 123 (15.7)
Missing 118 97
Marital status 0.01
Widowed/divorced 1381 (63.2) 484 (57.1)
Currently married 148 (6.8) 67 (7.9)
Never married 654 (30.0) 296 (34.9)
Missing 23 31
No. of children ,0.001
None 297 (13.7) 187 (22.4)
One 542 (25.1) 239 (28.7)
At least 2 1322 (61.2) 407 (48.9)
Missing 45 45
Source of income 0.01
Sex work alone 1227 (56.5) 523 (62.1)
Sex work and other job 844 (38.8) 276 (32.8)
No sex work 102 (4.7) 43 (5.1)
Missing 33 36
Where paying clients are
recruited by participants
,0.001
Bar, club, or restaurant 1040 (50.9) 356 (45.4)
Street 472 (23.1) 291 (37.1)
Several avenues 532 (26.0) 138 (17.6)
Missing 162 93
Reproductive health
Pregnancy status 0.02
Not pregnant 2048 (94.8) 812 (96.9)
Pregnant 112 (5.2) 26 (3.1)
Missing 46 40
Current contraceptive use ,0.001
None or other 1285 (61.7) 531 (68.9)
Oral cc 170 (8.2) 34 (4.4)
Inject 514 (24.7) 180 (23.3)
Pregnant 112 (5.4) 26 (3.4)
Missing 125 107
Behavioral characteristics
Frequency of paid sex in the
past 12 months
,0.001
Less than once a week/none 275 (12.6) 125 (14.6)
TABLE 2. (Continued ) Comparing the Enrollment
Characteristics for HIV-Negative Women With and Without
a Follow-up Visit
Characteristic
Follow-up Status, n (%)
At Least One
Follow-up
No Follow-
up Visit P
At least once a week 735 (33.5) 210 (24.5)
Daily 1181 (53.9) 522 (60.9)
Missing 15 21
No. of partners in the last month 0.07
,5 563 (27.0) 189 (24.3)
5–19 499 (23.9) 170 (21.8)
At least 20 or cannot
remember
1022 (49.0) 420 (53.9)
Missing 122 99
No. of paying partners in the last
month
0.10
,5 587 (28.2) 204 (26.3)
5–19 488 (23.4) 162 (20.8)
At least 20 1009 (48.4) 411 (52.9)
Missing 122 101
Condom use frequency with
paid sex in the last month
0.09
Inconsistent 883 (42.2) 297 (38.0)
Consistent (always) 969 (46.3) 397 (50.8)
No paid sex 241 (11.5) 88 (11.3)
missing 113 96
Alcohol consumption frequency 0.46
Nondrinker 488 (22.8) 203 (24.9)
Non–daily drinker 891 (41.6) 327 (40.2)
Daily drinker 762 (35.6) 284 (34.9)
Missing 65 64
Binge drinking within the past 3
months
0.01
Nondrinker 489 (22.7) 201 (24.2)
No binging 557 (25.8) 164 (19.7)
Binged 1112 (51.5) 466 (56.1)
Missing 48 47
Illicit drug use in the past 3
months
0.45
Not used drugs in the past 3
months
1513 (72.5) 562 (72.1)
Non–daily drug user 129 (6.2) 58 (7.4)
Daily drug user 444 (21.3) 159 (20.4)
Missing 120 99
HIV testing history ,0.001
.1 yr ago or never 788 (36.5) 202 (24.3)
7–12 months ago 309 (14.3) 95 (11.4)
,6 months ago 1064 (49.2) 535 (64.3)
Missing 45 46
Sexually transmitted infections
(STIs)*
No STI 1349 (63.2) 592 (72.8) ,0.001
With STI 787 (36.8) 221 (27.2)
*STI variable was a composite variable combining data on STI symptoms from
clinical examination and test results for STI for syphilis.
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compared with those where analyses were restricted to
women with at least 6 months of observation time. This is
because HIV incidence peaked within the ﬁrst 6 months, yet
participants were less likely to miss scheduled visits during
this period than later periods.26 After performing an interac-
tion of MSV with the cohort indicator variable in the ﬁnal
model adjusted for other confounders, results were also
compared for the 2 cohorts.
Figure 1 shows the relationship between MSV and
subsequent HIV risk and the relationships across factors
controlled for in the regression model. Although behavioral
factors and detection of STIs can inﬂuence attendance at the
study clinic, attendance can also inﬂuence reported behavioral
and STI outcomes. As a result, the Cox regression model
adjusted for time-dependent variables at the preceding visits.
Ordered categorical variables in the model were assessed for
extralinear variability using likelihood ratio tests by compar-
ing models with variables as categorical versus a linear ﬁt.
Analyses were performed using STATA 14 (StataCorp,
College Station, TX).
RESULTS
Cohort Characteristics
Of the 3084 HIV-negative women enrolled at the clinic,
2206 (71.5%) attended $1 follow-up visit after enrollment:
93.5% (605/647) in cohort-1 and 65.9% (1601/2437) in
cohort-2. Between the ﬁrst enrollment (April 2008) and end
of follow-up (Aug 2017), a total of 24,476 visits (cohort-1:
12,786, cohort-2: 11,690) had been scheduled by the last visit
of each participant with $1 follow-up visit. Of these, 17,486
(71.4%) scheduled visits (cohort-1: 9,462, cohort-2: 8024)
were attended. The median number of visits attended per
participant was 15 [interquartile range (IQR): 8–22] in cohort-
1 and 4 (IQR: 2–6) in cohort-2.
Table 2 compares enrollment characteristics for HIV-
negative women with and without a follow-up visit. In the
multivariable analysis (see Table 1, Supplemental Digital
Content, http://links.lww.com/QAI/B362), the factors associ-
ated with having no follow-up include younger age, fewer
children, street-based recruitment of clients, not on oral
contraceptives, less frequent paid sex, and consistently using
condoms with clients in the last month.
HIV Incidence
Among women with $1 follow-up visit, we observed
5540 person-years and 170 (7.7%) seroconversions, giving an
incidence rate of 3.1/100 person-years [95% conﬁdence
interval (CI): 2.6 to 3.5]. Overall incidence was similar in
the 2 cohorts (cohort-1: 93 seroconversions; incidence = 3.1/
100 person-years; cohort-2: 77 seroconversions; incidence =
3.0/100 person-years). HIV incidence declined after enroll-
ment, from 3.6/100 person-years within the ﬁrst year, 2.8/100
person-years in the second year, and 2.5/100 person-years
beyond 2 years of follow-up.
Figure 2 shows that episodes of 2 consecutively
attended visits during which HIV was diagnosed are longer
(have their distribution more skewed to the right) than those
with HIV-negative test results at both attended visits. After
restricting to episodes with $3 MSV, the median number of
MSV within each participant’s period of 2 consecutively
attended visits was 4 MSVs (IQR: 3–6), whereas one person
had the longest episode of 30 missed visits (Fig. 2). In
examining the potential confounders for the association of
MSV and HIV seroconversion (see Table 2, Supplemental
Digital Content, http://links.lww.com/QAI/B362), there was
evidence that the odds of being in higher categories of MSV
than in lower categories were independently associated with:
enrollment in cohort-2, longer follow-up, incomplete ordinary
secondary education level, street-based recruitment of clients,
being pregnant, reporting no paid sex within the last month,
alcohol consumption, illicit drug use in past 3 months, and
having no STI at the previous visit.
The number of MSVs seems to be positively correlated
with HIV incidence. HIV incidence was 2.6/100 person-years
(95% CI: 2.1 to 3.2) during episodes without missed visits,
3.0/100 person-years (95% CI: 2.2 to 4.1) in episodes with
1–2 MSV, and 4.3/100 person-years (95% CI: 3.3 to 5.6) in
episodes with $3 MSV (P value for trend = 0.003; Table 3).
The number of MSVs remained correlated with subsequent
increase in HIV risk even after taking account of differences in
cohort of enrollment, age of participant, education level, having
a stable sexual partner, location for recruiting clients, current type
of contraceptive, the number of men with paid sex in the last
month, frequency of condom use during paid sex, frequency of
alcohol consumption, and having a current STI (Table 3).
In this multivariable model, episodes with 1–2 MSV
were associated with 40% higher risk of HIV infection (aHR
= 1.40, 95% CI: 0.93 to 2.12) than episodes without a MSV,
but the evidence for this association was weak. However,
episodes with $3 MSV had twice the risk of HIV infection
(aHR = 2.00, 95% CI: 1.35 to 2.95) compared with that in
episodes without a MSV. Furthermore, there was strong
evidence in favor of the risk of HIV infection increasing with
the increasing number of MSV within episodes; P value for
trend = 0.001 and P-value for extralinear variability = 0.91.
The evidence for the association between MSV and
increased HIV incidence remained when analyses were
restricted to follow-up of .6 months [P value for trend
,0.001; aHR = 1.61 (95% CI: 1.00 to 2.58) for 1–2 MSV,
and aHR = 2.05 (95% CI: 1.31 to 3.22) for$3 MSV]. But the
estimated effect for the 1–2 MSV category was stronger in
this restricted analysis. Although there was no evidence that
the effect of MSV differed by cohort (P value for interaction
= 0.24), the results are also shown by cohort in Table 3,
Supplemental Digital Content, http://links.lww.com/QAI/
B362.
Other factors independently associated with increased
risk of HIV incidence included the following: not having
a stable sexual partner, recruiting clients from the street, not
being pregnant, and inconsistent condom use with clients.
DISCUSSION
Our ﬁndings demonstrate the importance of ensuring
sustained exposure to combined HIV-prevention
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interventions targeting women at high-risk of HIV infection
in the prevention of HIV. Sustained exposure is not only
likely to reinforce prevention interventions but also facilitate
earlier initiation of ART among those recently infected with
HIV. Participants attending the clinic had access to a range of
services including HIV and other sexual health and repro-
ductive services. At every visit, participants attended coun-
seling sessions where they were encouraged to modify or
maintain behaviors depending on their interview responses,
results from clinical examinations, and serological test.
Participants diagnosed with STIs were additionally given
treatment. Therefore, MSV within episodes of consecutive
attendances was a proxy for recent degree of exposure to
combined HIV-prevention interventions.
Compared with episodes without MSV, those with 1–2
MSV had 40% higher risk of HIV infection, whereas those
with $3 MSV had twice the risk. This dose–response rela-
tionship further supports the effectiveness of combination
HIV-prevention interventions among FSWs for improved
HIV-related outcomes such as consistent condom use with
clients, earlier treatment of STIs, and consequently, lower
HIV infection.6,7,31,32 However, this effectiveness is depen-
dent on good program adherence.
In addition, our ﬁndings are consistent with studies that
have suggested a link between the amount of exposure to HIV
interventions and improved HIV-related outcomes.21–23 Most
notable is a study in Côte d’Ivoire that conducted health talks,
provided condoms, treated STIs at monthly clinic visits, and
serological tests every 6 months.23 In this study, HIV
incidence was 4.6/100 person-years for women who attended
4 of the 5 scheduled visits before their last assessment and
13.0/100 person-years among those who attended fewer
visits.23 But a time-varying preceding gap in clinic attendance
of $60 days was associated with reduced HIV risk in
a Kenyan FSW cohort with monthly clinic visits.24 Although
the authors did not offer a reason for this association, it is
likely that participants who missed the monthly visits may
have had low-risk perception and, therefore, saw no need to
regularly attend visits. In addition, the variable indicating
a preceding gap was correctly analyzed as a confounder, but
where it is the main exposure of interest, the time-varying
variables in that analysis represent potential mediating
factors. Thus, these mediating factors underestimate the
overall effect of the preceding gap.
In our study, the mechanisms through which MSV
within episodes of consecutive visit attendances inﬂuence
HIV infection may be explained by interconnected factors
operating at the structural, behavioral, and biomedical levels.
Structural Factors
HIV determinants such as high mobility, economic
difﬁculties, and risky work environments of FSWs may
underlie the risk associated with MSV. Although the ability
to take risks (being a more risky individual) could inﬂuence
an individual to be mobile in search of work; mobility itself
can affect the risk of HIV if there is risk of HIV associated
with the new environment/place (ie, the new place has high
HIV prevalence, low condom use, and low ART coverage or
adherence). A previous qualitative study in this cohort
reported that participants commonly moved to ﬁshing com-
munities for extended periods in search of clients.15 These
communities have been linked with high HIV prevalence and
incidence, yet the ﬁshermen usually preferred condomless
sex, thus increasing HIV vulnerabilities for the mobile
participants.33
Other ﬁndings in this cohort are a signal to the potential
economic pressures facing participants to not only deter them
from accessing the much-needed clinic services but also
affecting their ability to refuse sex with a client paying more
for noncondom use. For example, when transport refund for
participants was stopped in January 2013, the rate of MSV
among those attending each visit increased substantially from
10% to 30%.26 Furthermore, some 5% of participants
reported lack of transport as a cause for missing 2 or more
FIGURE 2. Distribution for the number of MSVs
within each participant’s episodes of 2 consecu-
tively attended visits by HIV seroconversion status
in the episodes.
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TABLE 3. Association of HIV Seroconversion With the Number of Missed Visits Between Consecutively Attended Visits Based on
the Cox Regression Model
Characteristic
New HIV Cases/pyr
(Rate/100 pyr)
Crude Hazard Ratio
(95% CI) P
Adjusted Hazard Ratio
(95% CI) P
Overall (both cohort) 170/5540 (3.1)
No. of visits missed between attendances
No missed visit 81/3106 (2.6) 1 0.003* 1 0.001*
One/2 missed visit(s) 38/1250 (3.0) 1.18 (0.80 to 1.74) 1.40 (0.93 to 2.12)
At least 3 missed visits 51/1180 (4.3) 1.77 (1.23 to 2.54) 2.00 (1.35 to 2.95)
Sociodemographic
Cohort of enrollment
Cohort-1 93/3003 (3.1) 1 0.45 1 0.43
Cohort-2 77/2537 (3.0) 0.87 (0.61 to 1.24) 0.85 (0.56 to 1.27)
Calendar period†
Jan 2013–Dec 2014 46/1394 (3.3) 1 0.16
Jan 2015–Aug 2017 65/2138 (3.0) 0.99 (0.64 to 1.55)
Apr 2008–Dec 2012 59/2007 (2.9) 1.09 (0.70 to 1.70)
Age in years
,25 53/1562 (3.4) 1 0.49 1 0.37
25–34 92/2955 (3.1) 0.96 (0.68 to 1.35) 0.86 (0.60 to 1.24)
At least 35 25/994 (2.5) 0.76 (0.46 to 1.24) 0.80 (0.48 to 1.33)
With a stable sexual partner§
Yes 113/3959 (2.9) 1 0.01 1 0.003
No 57/1211 (4.7) 1.55 (1.13 to 2.14) 1.75 (1.23 to 2.50)
Highest education level at enrollment
Incomplete primary level 74/2361 (3.1) 1 0.03 1 0.24
Completed primary to incomplete O level 70/2267 (3.1) 0.97 (0.70 to 1.35) 1.06 (0.76 to 1.49)
Completed secondary O level above 25/792 (3.2) 1.00 (0.63 to 1.57) 1.20 (0.75 to 1.92)
Marital status§
Widowed/divorced 112/3325 (3.4) 1 0.33
Currently married 28/1150 (2.4) 0.77 (0.50 to 1.17)
Never married 30/1044 (2.9) 0.81 (0.54 to 1.22)
No. of children§
None 21/583 (3.6) 1 0.41
One 42/1247 (3.4) 0.94 (0.56 to 1.59)
At least 2 107/3665 (2.9) 0.81 (0.51 to 1.30)
Source of income§
Sex work alone 74/2241 (3.3) 1 0.13
Sex work and other job 73/2416 (3.0) 0.94 (0.68 to 1.31)
No sex work 23/851 (2.7) 0.89 (0.54 to 1.45)
Recruitment of clients§
Bar, club, or restaurant 76/2717 (2.8) 1 0.01 1 0.004
Street 46/888 (5.2) 1.78 (1.23 to 2.57) 1.89 (1.27 to 2.80)
Several avenues 48/1634 (2.9) 1.07 (0.75 to 1.54) 0.98 (0.68 to 1.42)
Reproductive health
Current contraceptive use§
None or other 100/3160 (3.2) 1 0.001 1 ,0.001
Oral cc 12/526 (2.3) 0.73 (0.40 to 1.33) 0.70 (0.38 to 1.28)
Inject 56/1378 (4.1) 1.29 (0.93 to 1.80) 1.35 (0.96 to 1.88)
Pregnant 2/397 (0.5) 0.16 (0.04 to 0.66) 0.13 (0.03 to 0.55)
Behavioral characteristics
No. of sexual partners§
,5 77/2765 (2.8) 1 0.30
5–19 32/1119 (2.9) 0.97 (0.64 to 1.49)
At least 20 or cannot remember 61/1543 (4.0) 1.29 (0.90 to 1.84)
(continued on next page)
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consecutive visits based on records of 342 HIV-negative
women contacted between October and December 2015.
The social components of targeted HIV interventions such
as peer outreach are not only critical in facilitating clinic
attendance but are also associated with increased consistent
condom use among FSWs.18,20 Some of the participants with
MSV might also have had limited engagement with peer
educators as well as with outreach services, particularly
participants working in isolation such as street or phone-based
FSWs. Yet, our ﬁndings show that street-based FSWs were
more likely to miss study visits and to acquire HIV infection
than those who recruit clients from facilities such as bars or
clubs. Among other reasons, street-based FSWs in this cohort as
in other studies report a particularly higher risk of sexual or
physical violence and exploitation by clients and law enforcers
than venue-based FSWs.16,18,34 Consequently, they are likely to
be at a greater risk of STIs and HIV than those based in facilities.
Furthermore, participants starting out in sex work are usually
young and without social support networks to help them manage
daily risks, including getting support for attending clinic visits.16
These young participants are likely to be more isolated, more
stigmatized, and to be highly vulnerable.34–37 Therefore, targeted
programmes should work with potentially isolated groups of
women at high risk of HIV (such as the highly mobile or young
women) to develop better delivery models for services, which
models could include scaling-up and intensifying mobile night
clinics and intensifying peer outreach.20,38,39
Behavioral Factors
Regular attendance of a dedicated clinic creates oppor-
tunities for reinforcing individual behavioral change messages
among women at high risk of HIV. HIV prevention behavior
can be achieved and sustained when participants are continu-
ally provided with appropriate information, are motivated to
act, and enabled to obtain behavioral skills. These are key
elements of the information–motivational–behavioral skill
model that has been proposed for ART adherence but can also
be applied for behavioral change among women at high risk of
HIV.40 In our study, trained counselors provide information on
HIV prevention to participants through interactive sessions.
Similar interactive sessions have been credited by FSWs in
Zimbabwe for improving awareness of self-care as well as
prevention and treatment of HIV and STIs.19 Also, during
TABLE 3. (Continued ) Association of HIV Seroconversion With the Number of Missed Visits Between Consecutively Attended Visits
Based on the Cox Regression Model
Characteristic
New HIV Cases/pyr
(Rate/100 pyr)
Crude Hazard Ratio
(95% CI) P
Adjusted Hazard Ratio
(95% CI) P
No. of men the participant had paid sex
within the last month§
,5 79/2816 (2.8) 1 0.14 1 0.29
5–19 27/1089 (2.5) 0.84 (0.54 to 1.32) 0.70 (0.43 to 1.14)
At least 20 or cannot remember 60/1522 (3.9) 1.29 (0.90 to 1.85) 0.96 (0.62 to 1.47)
Condom use frequency with paid sex in the
last month§
Inconsistent 72/1616 (4.5) 1 0.01 1 0.002
Consistent (always) 55/2223 (2.5) 0.56 (0.40 to 0.80) 0.51 (0.35 to 0.74)
No paid sex 43/1601 (2.7) 0.64 (0.43 to 0.96) 0.76 (0.48 to 1.20)
Alcohol consumption frequency§
Nondrinker 49/1870 (2.6) 1 0.30 1 0.41
Non–daily drinker 68/2202 (3.1) 1.17 (0.81 to 1.70) 1.17 (0.79 to 1.73)
Daily drinker 53/1418 (3.7) 1.37 (0.92 to 2.04) 1.34 (0.87 to 2.07)
Binge drinking in past 3 months§
Nondrinker 48/1847 (2.6) 1 0.21
No binging 58/1617 (3.6) 1.41 (0.95 to 2.07)
Binged 64/2039 (3.1) 1.14 (0.78 to 1.67)
Illicit drug use in the past 3 months§
No 122/3949 (3.1) 1 0.34
Yes 48/1260 (3.8) 1.18 (0.84 to 1.66)
Sexually transmitted infections (STIs)§‡
No STI 109/4033 (2.7) 1 0.01 1 0.12
With STI 61/1471 (4.1) 1.49 (1.09 to 2.05) 1.31 (0.93 to 1.85)
Adjusted for: cohort of enrollment, age at follow-up in years, having a stable sexual partner (both married and unmarried), highest education level at enrollment, where clients are
recruited from, current contraceptive use, condom use frequency with paid sex in the last month at follow-up, alcohol consumption frequency at follow-up, and presence of a sexually
transmitted infection at follow-up.
*Test for linear trend. Pyr—person-years of observation.
†The calendar period of January 2013–December 2014 was common to both cohorts (cohort-1 and cohort-2) because cohort-2 was initiated in January 2013 and was, therefore,
used as the reference category.
‡STI variable was a composite variable combining data on STI symptoms from clinical examination and test results for STI for syphilis.
§Data collected at enrollment and follow-up study visits.
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ongoing risk-reduction counseling sessions in our study,
participants are motivated to improve or maintain healthy
behaviors. This motivation may not only facilitate the adoption
of healthy behaviors but also inﬂuence participants to regularly
attend the clinic. Attending follow-up visits at the clinic was
associated with higher parity, being on oral contraceptives, and
having had an STI at the previous visit, which factors also
reﬂect some underlying motivations related with the services
offered at the clinic. According to the
information–motivational–behavioral model, ongoing infor-
mation on HIV prevention and motivation to stay healthy
would act through acquired behavioral skills such as correct
use of condoms to inﬂuence HIV incidence.
Therefore, participants who miss study visits are likely
to also miss opportunities for reinforcing HIV risk-reduction
behaviors. In addition, the HIV risk associated with MSV
may increase where the participant’s decision to attend the
clinic is inﬂuenced by new intimate relationships. When
participants start new intimate relationships, they might be
afraid to associate with the clinic and they could be stopped
by spouses from attending the dedicated clinic. In participants
who missed $2 consecutive visits, 10% reported the reason
as being in a new stable relationship or being stopped by
a spouse. In this cohort as elsewhere, it is not uncommon for
some of these new relationships to involve paying clients who
transitioned into regular partnerships.16,34 These partnerships
have not only been associated with limited condom use which
is usually seen as a sign of mistrust within intimate relation-
ships across Africa but also with high HIV burdens.16,41
Biomedical Factors
Regular attendance of a dedicated clinic enables timely
access to biomedical interventions for prevention, treatment,
and care. For example, 18% of all syndrome-based STIs
might not have been detected if FSWs had not attended the
clinic in a large study in Southern India on the impact of peer
outreach on clinic utilization reported.20 Similarly, the clinical
examination at our study clinic is likely to facilitate earlier
diagnosis and treatment of STIs for those regularly attending
the clinic. As a result, earlier treatment would reduce the
efﬁciency of STIs for HIV transmission.
Despite the substantial decline in HIV incidence after
enrollment that was recently observed in this cohort, the
incidence remained high and persisted over time.26 HIV
incidence also remained high during episodes with no MSV,
although it was substantially lower in these episodes com-
pared with those with at least 3 MSV. This persistently high
HIV incidence despite combined HIV-prevention efforts may
suggest presence of potential barriers in HIV control among
women at high risk of HIV in this cohort. Among other
factors, HIV control may be hindered by common barriers
reported across studies in Africa such as accepting offers of
sex without condoms for more money, hazardous alcohol use,
and sexual and physical violence among women at high risk
of HIV.18,34,42–44 To further interrupt the spread of HIV
through sex work, there is a need to strengthen targeted HIV-
prevention efforts by integrating promising direct biomedical
interventions such as pre-exposure prophylaxis, strengthening
risk-reduction interventions for substance abuse, and perhaps
implementing mental health interventions.45–48 These
individual-level interventions should be further supported
by structural interventions such as community empowerment
that ensure targeted services are supplied and delivered to all
women at high risk of HIV. Community empowerment
conceptualized as an active involvement of sex workers,
and the community in targeted activities could also reduce on
the interconnected HIV risk factors for social stigmas,
discrimination, and violence.6,8,49 More importantly, there is
need to monitor and strengthen regular engagement between
women at high risk of HIV and service providers including
their attendance at clinic services in the design and imple-
mentation of HIV-prevention interventions. Intensiﬁed peer
outreach is associated with improved clinic utilization among
FSWs and may be particularly important among isolated
groups such as street-based FSWs.19–21
We note some key limitations. The measurement of
MSV and seroconversion within the same episode could lead
to some misclassiﬁcation for the timing of seroconversions in
the episodes with MSV if seroconversion occurred earlier
before the missed visits. However, we assigned the timing of
seroconversion as a random date rather than the commonly
used midpoint to reduce on the potential for overestimation of
HIV risk during episodes with MSVs.25,26 Also, the number
of events per predictor variable (EPV) in the multivariable
model was relatively low (8.5) compared with the
recommended minimum EPV of 10.50 Although this low
EPV can affect model-based inferences, the strong evidence
for the association between MSV and HIV incidence in both
the simple and multivariable models suggests that our
conclusions could be valid. Similarly, data on some important
risk factors such as duration of sex work were not collected,
meaning this association could be confounded. Furthermore,
the study did not fully record reasons for MSV and on
a longitudinal basis, which would have facilitated better
understanding of what underlies the HIV risk associated
with MSV.
In conclusion, the need for scaling-up targeted combi-
nation HIV-prevention and treatment interventions for FSWs
has been emphasized, but this study stresses the importance of
monitoring, facilitating, and sustaining exposure to these
services once women at high risk of HIV have been linked to
services. Sustained exposure reinforces HIV prevention and
facilitates earlier initiation of ART among those recently
infected with HIV. Therefore, HIV programmes should
include moving a wider scope of services to HIV-
vulnerable women who are unable or unwilling to attend
clinic services, particularly those working outside of estab-
lished venues such as street-based FSWs.
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